These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Chromogenic and fluorogenic glycosylated and acetylglycosylated peptides as substrates for serine, thiol and aspartyl proteases. Juliano MA, Filira F, Gobbo M, Rocchi R, Del Nery E, Juliano L. J Pept Res; 1999 Feb; 53(2):109-19. PubMed ID: 10195448 [Abstract] [Full Text] [Related]
27. Substrate specificity of ascidian sperm trypsin-like proteases, spermosin and acrosin. Sawada H, Someno T. Mol Reprod Dev; 1996 Oct; 45(2):240-3. PubMed ID: 8914083 [Abstract] [Full Text] [Related]
28. Evidence for the presence of five distinct proteolytic components in the pituitary multicatalytic proteinase complex. Properties of two components cleaving bonds on the carboxyl side of branched chain and small neutral amino acids. Orlowski M, Cardozo C, Michaud C. Biochemistry; 1993 Feb 16; 32(6):1563-72. PubMed ID: 8431436 [Abstract] [Full Text] [Related]
29. Substituted isocoumarins as inhibitors of complement serine proteases. Kam CM, Oglesby TJ, Pangburn MK, Volanakis JE, Powers JC. J Immunol; 1992 Jul 01; 149(1):163-8. PubMed ID: 1607651 [Abstract] [Full Text] [Related]
30. The substrate specificity of proteinase B from baker's yeast. Kominami E, Hoffschulte H, Leuschel L, Maier K, Holzer H. Biochim Biophys Acta; 1981 Sep 15; 661(1):136-41. PubMed ID: 7028121 [Abstract] [Full Text] [Related]
31. Substrate specificities and inhibition of two hemorrhagic zinc proteases Ht-c and Ht-d from Crotalus atrox venom. Fox JW, Campbell R, Beggerly L, Bjarnason JB. Eur J Biochem; 1986 Apr 01; 156(1):65-72. PubMed ID: 3514216 [Abstract] [Full Text] [Related]
32. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides. Lesavre P, Gaillard MH, Halbwachs-Mecarelli L. Eur J Immunol; 1982 Mar 01; 12(3):252-4. PubMed ID: 6920299 [Abstract] [Full Text] [Related]
35. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B. Gronski P, Bodenbender L, Kanzy EJ, Piepenbrock M, Seiler FR. Immunobiology; 1986 Apr 01; 171(3):252-62. PubMed ID: 3011651 [Abstract] [Full Text] [Related]
37. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb. Fujita T, Inoue T, Ogawa K, Iida K, Tamura N. J Exp Med; 1987 Nov 01; 166(5):1221-8. PubMed ID: 2445886 [Abstract] [Full Text] [Related]
38. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement. Farries TC, Lachmann PJ, Harrison RA. Biochem J; 1988 Aug 01; 253(3):667-75. PubMed ID: 3140783 [Abstract] [Full Text] [Related]
39. Mapping the substrate binding site of human C1r and C1s with peptide thioesters. Development of new sensitive substrates. McRae BJ, Lin TY, Powers JC. J Biol Chem; 1981 Dec 10; 256(23):12362-6. PubMed ID: 6271784 [No Abstract] [Full Text] [Related]
40. A multicatalytic high-molecular-weight neutral endopeptidase from human kidney. Zolfaghari R, Baker CR, Amirgholami A, Canizaro PC, Behal FJ. Arch Biochem Biophys; 1987 Oct 10; 258(1):42-50. PubMed ID: 3310903 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]